Dorsomorphin Suppresses EMT to Reduce AR‐Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2‐Independent Shh Activation

Documenti analoghi

• Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
  di: Hyun‐Kyung Ko, et al.
  Pubblicazione: (2025)
• pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
  di: Piotr Bialas, et al.
  Pubblicazione: (2024)
• Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
  di: Anna‐Lena Lemster, et al.
  Pubblicazione: (2025)
• Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer
  di: Ali Fuat Gürbüz, et al.
  Pubblicazione: (2026)
• Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population
  di: Fangming Wang, et al.
  Pubblicazione: (2026)